drugset / Trial / NCT00405431

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

NCT00405431

Completed 43 enrolled Wills Eye Allergan · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.

Timeline

Start
2004-03
Primary completion
2005-06
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.05 % Topical

Indications